Page 33 - Read Online

Padoan et al. Vessel Plus 2021;5:41 https://dx.doi.org/10.20517/2574-1209.2021.41 Page 15 of 18

12. Rahmattulla C, De Lind van Wijngaarden RAF, Berden AE, et al. Renal function and ear, nose, throat involvement in anti-neutrophil
cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials. Rheumatology
(Oxford) 2015;54:899-907. DOI PubMed
13. Hogan SL, Falk RJ, Chin H, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated
small-vessel vasculitis. Ann Intern Med 2005;143:621. DOI PubMed
14. Trimarchi M, Sinico RA, Teggi R, et al. Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s).
Autoimmun Rev 2013;12:501-5. DOI PubMed
15. Comarmond C, Pagnoux C, Khellaf M, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics
and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 2013;65:270-81.
DOI PubMed
16. Durel C-A, Berthiller J, Caboni S, et al. Long-term followup of a multicenter cohort of 101 patients with eosinophilic granulomatosis
with polyangiitis (Churg-Strauss). Arthritis Care Res (Hoboken) 2016;68:374-87. DOI PubMed
17. Millet A, Pederzoli-Ribeil M, Guillevin L, et al. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the
group? Ann Rheum Dis 2013;72:1273-9. DOI PubMed
18. Gubbels SP, Barkhuizen A, Hwang PH. Head and neck manifestations of wegener’s granulomatosis. Otolaryngol Clin North Am
2003;36:685-705. DOI PubMed
19. Rasmussen N. Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist’s
perspective. Curr Opin Rheumatol 2001;13:3-11. DOI PubMed
20. Kwan ASL, Rose GE. Lacrimal drainage surgery in Wegener’s granulomatosis. Br J Ophthalmol 2000;84:329-31. DOI PubMed
PMC
21. Kühn D, Hospowsky C, Both M, et al. Manifestation of granulomatosis with polyangiitis in head and neck. Clin Exp Rheumatol
2018;36 Suppl 111:78-84. PubMed
22. Holme SS, Moen JM, Kilian K, et al. Development of CT-based methods for longitudinal analyses of paranasal sinus osteitis in
granulomatosis with polyangiitis. BMC Med Imaging 2019;19:13. DOI PubMed PMC
23. Muhle C, Reinhold-Keller E, Richter C, et al. MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener’s granulomatosis.
Eur Radiol 1997;7:566-70. DOI PubMed
24. Wojciechowska J, Krajewski W, Krajewski P, et al. Granulomatosis With polyangiitis in otolaryngologist practice: a review of
current knowledge. Clin Exp Otorhinolaryngol 2016;9:8-13. DOI PubMed PMC
25. Bacciu A, Bacciu S, Mercante G, et al. Ear, nose and throat manifestations of Churg-Strauss syndrome. Acta Otolaryngol
2006;126:503-9. DOI PubMed
26. Olsen KD, Neel HB, Deremee RA, et al. Nasal manifestations of allergic granulomatosis and angiitis (Churg-Strauss syndrome).
Otolaryngol Head Neck Surg 1980;88:85-9. DOI PubMed
27. Suzuki M, Nakazono A, Morita S, et al. Comparison of clinical characteristics of the nasal manifestations of eosinophilic
granulomatosis with polyangiitis (EGPA) and eosinophilic chronic rhinosinusitis (ECRS). Allergol Int 2021;70:143-4. DOI PubMed
28. Brescia G, Padoan R, Schiavon F, et al. Nasal polyps in eosinophilic granulomatosis with polyangiitis: structured histopathology and
CD105 expression. Am J Otolaryngol Head Neck Med Surg 2020;41:102661. DOI PubMed
29. Contro G, Brescia G, Alessandrini L, et al. Neutrophil infiltrates and eosinophil aggregates in chronic rhinosinusitis with nasal polyps
and EGPA. Clin Rheumatol ;2021:40:1949-57. DOI PubMed
30. Brescia G, Schiavon F, Nicolè L, et al. No differences in nasal tissue inflammatory cells and adhesion molecules (iCAM-1 and
vCAM-1) based on the comparison of EGPA with eosinophilic chronic sinusitis with polyposis. Am J Rhinol Allergy 2019;33:395-
402. DOI PubMed
31. Rahne T, Clauß F, Plontke SK, et al. Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with
polyangiitis (GPA, Wegener’s granulomatosis), or systemic lupus erythematosus. Clin Rheumatol 2017;36:1501-10. DOI PubMed
32. Martinez Del Pero M, Walsh M, Luqmani R, et al. Long-term damage to the ENT system in Wegener’s granulomatosis. Eur Arch
Otorhinolaryngol 2011;268:733-9. DOI PubMed
33. Girasoli L, Cazzador D, Padoan R, et al. Update on vertigo in autoimmune disorders, from diagnosis to treatment. J Immunol Res
2018;2018:5072582. DOI PubMed PMC
34. Nogaki T, Keskin N, Azuma T, et al. Quantitative assessment of vestibular otopathology in granulomatosis with polyangitis: a
temporal bone study. Laryngoscope Investig Otolaryngol 2018;3:473-7. DOI PubMed PMC
35. Ono N, Niiro H, Ueda A, et al. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center
study in Japan. Rheumatol Int 2015;35:555-9. DOI PubMed
36. Schirmer JH, Wright MN, Herrmann K, et al. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-positive
granulomatosis with polyangiitis (Wegener’s) is a clinically distinct subset of ANCA-associated vasculitis: a retrospective analysis of
315 patients from a German vasculitis referral center. Arthritis Rheumatol 2016;68:2953-63. DOI PubMed
37. Ralli M, D’Aguanno V, Di Stadio A, et al. Audiovestibular symptoms in systemic autoimmune diseases. J Immunol Res
2018;2018:5798103. DOI PubMed PMC
38. Seccia V, Fortunato S, Cristofani-Mencacci L, et al. Focus on audiologic impairment in eosinophilic granulomatosis with
polyangiitis. Laryngoscope 2016;126:2792-7. DOI PubMed
39. Nakamaru Y, Takagi D, Suzuki M, et al. Otologic and rhinologic manifestations of eosinophilic granulomatosis with polyangiitis.
Audiol Neurotol 2016;21:45-53. DOI PubMed
40. Harabuchi Y, Kishibe K, Tateyama K, et al. Clinical characteristics, the diagnostic criteria and management recommendation of otitis